Vnitr Lek 2025, 71(6):353-358 | DOI: 10.36290/vnl.2025.067

Allergy to insect stings - clear rules, but also new questions

Martina Vachová
Ústav imunologie a alergologie, Fakultní nemocnice Plzeň a Lékařská fakulta v Plzni, Univerzita Karlova

The most serious clinical manifestation of insect venom allergy is life-threatening anaphylaxis. European epidemiological data clearly confirm that insect stings are the most common trigger of this severe systemic allergic reaction in adults, surpassing even medications and foods in this regard. Another manifestation of insect venom allergy is large local reaction around the site of the insect sting. From a clinical point of view, these reactions are significantly less serious than systemic reactions, but even extensive local swelling can bother the patient for several days. The aim of this article is to present current diagnostic and treatment procedures for patients with insect venom allergy. These procedures depend entirely on the nature of the reaction and vary significantly between patients with local and systemic allergic sting reactions. The severity of the reaction is decisive for the indication of allergological examination, determines the selection of emergency medication, and is essential in the indication of venom immunotherapy. Recommendations for patients who have already experienced an allergic insect sting reaction are clearly defined and are part of the basic knowledge of an allergist. However, the problem with insect sting allergies is that it is not possible to identify individuals at risk of this allergy in advance. This is due to the very high prevalence of so-called asymptomatic sensitization to insect venoms in the general population, which discredits the benefits of preventive screening for this type of allergy.

Keywords: hymenoptera venom allergy (HVA), molecular diagnostics (component resolved diagnostics, CRD), basophil activation test (BAT), systemic sting reaction (SR), large local reaction (LLR), venom immunotherapy (VIT), asymptomatic sensitization.

Accepted: September 21, 2025; Published: October 2, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vachová M. Allergy to insect stings - clear rules, but also new questions. Vnitr Lek. 2025;71(6):353-358. doi: 10.36290/vnl.2025.067.
Download citation

References

  1. Vachová M. Alergie na blanokřídlý hmyz. Postgrad Med. 2019;21(4):291-296.
  2. Rybníček O, Seberová E. Průvodce alergenovou imunoterapií. Tigis. 2021.
  3. Bilò BM, Rueff F, Mosbech H, et al. Diagnosis of Hymenoptera venom allergy. Allergy. 2005;60(11):1339-1349. Go to original source...
  4. Sturm GJ, Varga EM, Roberts G, et al. EAACI guidelines on allergen immunotherapy: Hymenoptera venom allergy. Allergy. 2018;73(4):744-764. Go to original source...
  5. Sturm GJ, Arzt-Gradwohl L. An algorithm for the diagnosis and treatment of Hymenoptera venom allergy, 2024 update. Allergy. 2024;79(8):2298-2301. Go to original source...
  6. Vachová M, Panzner P. Diagnostika alergie na jed Hymenopter. Alergie. 2017;3:165-171.
  7. Vachová M, Kučera T. Imunoterapie hmyzími jedy v otázkách a odpovědích - kapesní manuál (1. část: Indikace a kontraindikace imunoterapie hmyzími jedy). Alergie. 2024;26(3):175-181.
  8. Bilò MB, Cichocka-Jarosz E, Pumphrey R, et al. Self-medication of anaphylactic reactions due to Hymenoptera stings - an EAACI Task Force Consensus Statement. Allergy. 2016;71(7):931-943. Go to original source...
  9. Vachová M, Kučera T. Imunoterapie hmyzími jedy v otázkách a odpovědích - kapesní manuál (2. část: bezpečnost, účinnost, praktické aspekty vedení léčby). Alergie. 2024;26(4):235-239. Go to original source...
  10. Tripolt P, Arzt-Gradwohl L, Čerpes U, et al. Large local reactions and systemic reactions to insect stings: Similarities and differences. PLoS One. 2020;15(4):e0231747. Go to original source...
  11. Bilò MB, Bonifazi F. The natural history and epidemiology of insect venom allergy: clinical implications. Clin Exp Allergy. 2009;39(10):1467-1476. Go to original source...
  12. Ring J, Messmer K. Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet. 1977;1:466-469. Go to original source...
  13. Vachová M. Anafylaxe - akutní a dlouhodbý management. Vnitř Lék. 2020;66(6):335-339. Go to original source...
  14. Feás X, Vidal C, Remesar S. What We Know about Sting-Related Deaths? Human Fatalities Caused by Hornet, Wasp and Bee Stings in Europe (1994-2016). Biology (Basel) [Internet]. 2022;11(2):282. Go to original source...
  15. Cross B, Choudhury TR, Hindle M, et al. Wasp sting induced STEMI with complete coronary artery occlusion: a case of Kounis syndrome. BMJ Case Rep. 2017;2017:bcr2017221256. Go to original source...
  16. Sturm GJ, Kranzelbinder B, Schuster C, et al. Sensitization to Hymenoptera venoms is common, but systemic sting reactions are rare. J Allergy Clin Immunol. 2014;133(6):1635-1643.e1. Go to original source...
  17. Sturm GJ, Schuster C, Kranzelbinder B, et al. Asymptomatic sensitization to hymenoptera venom is related to total immunoglobulin E levels. Int Arch Allergy Immunol. 2009;148(3):261-264. Go to original source...
  18. Pucci S, D'Alò S, De Pasquale T, et al. Risk of anaphylaxis in patients with large local reactions to hymenoptera stings: a retrospective and prospective study. Clin Mol Allergy [Internet]. 2015;13:21. Go to original source...
  19. Ruëff F, Bauer A, Becker S, et al. Diagnosis and treatment of Hymenoptera venom allergy: S2k Guideline of the German Society of Allergology and Clinical Immunology (DGAKI)… Allergol Select. 2023;7:154-190. Go to original source...
  20. Golden DBK. Venom allergen immunotherapy. Allergy Asthma Proc. 2022;43(4):339-343. Go to original source...
  21. Jakob T, Müller U, Helbling A, et al. Component resolved diagnostics for hymenoptera venom allergy. Curr Opin Allergy Clin Immunol. 2017;17:363-372. Go to original source...
  22. Arzt L, Bokanovic D, Schrautzer C, et al. Questionable diagnostic benefit of the commercially available panel of bee venom components. Allergy. 2017;72:1419-1422. Go to original source...
  23. Vachová M, Panzner P, Kopač P, et al. Routine clinical utility of honeybee venom allergen components. J Allergy Clin Immunol Pract [Internet]. 2018;6:2121-2123.e1. Go to original source...
  24. Schnidle P, Blank S, Altrichter S, et al. Basophil activation test in double sensitized patients with hymenoptera venom allergy: Additional benefit of component-resolved diagnostics. J Allergy Clin Immunol Pract. 2023;11:2890-2900. Go to original source...
  25. Korosec P, Erzen R, Silar M, et al. Basophil responsiveness in patients with insect sting allergies and negative venom-specific immunoglobulin E and skin prick test results. Clin Exp Allergy. 2009;39:1730-1737. Go to original source...
  26. Bonadonna P, Bonifacio M, Lombardo C, et al. Hymenoptera Allergy and Mast Cell Activation Syndromes. Curr Allergy Asthma Rep. 2016;16(1):5. Go to original source...
  27. Alvarez-Twose I, González-de-Olano D, Sánchez-Muñoz L, et al. Validation of the REMA score for predicting mast cell clonality and systemic mastocytosis in patients with systemic mast cell activation symptoms. Int Arch Allergy Immunol. 2012;157(3):275-280. Go to original source...
  28. Korošec P, Sturm GJ, Lyons JJ, et al. High burden of clonal mast cell disorders and hereditary α-tryptasemia in patients who need Hymenoptera venom immunotherapy. Allergy. 2024;79(9):2458-2469. Go to original source...
  29. Muraro A, Roberts G, Worm M, et al. Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology. Allergy. 2014;69(8):1026-1045. Go to original source...
  30. Vachová M. Doporučení výboru České společnosti alergologie a klinické imunologie k použití adrenalinového autoinjektoru. Alergie. 2018;20:260.
  31. Vachová M. Alergie na včelí a vosí jed. Remedia. 2020;30:68-71.
  32. Sturm GJ, Herzog SA, Aberer W, et al. β-blockers and ACE inhibitors are not a risk factor for severe systemic sting reactions and adverse events during venom immunotherapy. Allergy. 2021;76(7):2166-2176. Go to original source...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.